Go to home page - PHARMAC - Pharmaceutical Management Agency
Leading Edge Medicines Management home

This is the text extract for Proposals to..., browse documents here.


Metadata

Title

Proposals to...

Abstract

• list glatiramir acetate (Copaxone) in Section B of the Pharmaceutical Schedule • widen access to oxaliplatin (Eloxatin) • contract for oxaliplatin (Eloxatin), colaspase/L-asparaginase (Leunase) and docetaxel (Taxotere)

Page 1

icon

Note

This text has been extracted from the source PDF document.

Also available as plain text.

Please contact webmaster to discuss alternative format options.